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Abstract
There is a clear correlation between excessive sun exposure and the development of skin cancer. UVB radiation from the sun 
is potent, and as the ozone layer gets depleted, more UVB can reach Earth and cause cell damage. UV radiation causes DNA 
lesions, such as 6-4 photoproducts and cyclobutane pyrimidine dimers. Cyclobutane pyrimidine dimers are more abundant and 
take longer to be repaired and therefore are responsible for most of the mutation and DNA damage. These DNA lesions lead to 
mutation of the p53 gene. The signature mutation on p53 from UV radiation is a CC to TT mutation, which generally occurs at 
the binding site of p53. As a result, of the mutation, p53 is inactivated and can no longer perform its tumor suppressive functions. 
As a result, cancerous or damaged cells in the skin can proliferate and form tumors. P53 is an early step in skin carcinogenesis, 
and p53 mutation is found in abundance in actinic keratosis, a precancerous lesion of Squamous Cell Carcinoma. Experiments 
conducted on mice prove the effectiveness of sunscreen. Mice treated with UVB blocking sunscreen had significantly decreased 
percentage of mutation, compared to mice without the sunscreen.
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Introduction
When summer comes around, it is quite challenging to find a 
place to sit at the beach. The sands are covered with people sun-
bathing and basking in the sunlight. Although it is widely known 
that excessive sun exposure directly correlates to the onset of 
skin cancer, many people feel that they are immune to the sun’s 
harmful rays and therefore will not develop skin cancer. However, 
this is not the case, and as they lie there, in denial of the harmful 
effects of the sun’s radiation, they are hurting their bodies. Tanning 
may cause a more appealing appearance , but in just a few years 
the harmful effects can emerge and cause a quite dangerous con-
dition, long after the beauty wears away. Sitting directly in the sun, 
especially without sunscreen, is understandably harmful, but what 
many people do not realize is that even in cloudy weather eighty 
percent of the sun’s rays can penetrate through the clouds and 
can still affect the skin (Bowes, 2012). No matter the weather, 
spending too much time outdoors without the proper protection 
is detrimental to a person’s skin. 
In the United States alone there are approximately 500,000 
cases of basal cell carcinoma (BCC) and 100,00 to 150,000 cases 
if squamous cell carcinoma (SCC) reported every year (Kanjilal 
et al., 1995). Sun exposure proves to be the major factor in the 
formation of these cancers. Melanoma generally is caused by 
short incidents of high intensity ultraviolet (UV) radiation. On 
the other hand, BCC and SCC, known as the non-melanoma 
skin cancers (NMSC) are generally caused by incidents of ex-
posure to UV radiation which gradually build up. Since NMSC 
is a result of the collective UV radiation absorption, it is more 
commonly found in older people (Armstrong and Cust, 2017). 
Generally skin cancer is more prevalent among fair skinned 
people, who have less melanin, pigment, which acts as a barrier 
to UV radiation. Moreover, people who live close to the equator 
are also at a greater risk for solar UV induced skin cancer, as the 
sun’s rays hit Earth most directly at equator. 
No matter the skin tone, too much sun exposure can lead 
to various issues, such as inflammation, photoaging, erythema, 
sunburn, eye damage, DNA damage and skin cancer (Benjamin 
et al., 2007). UV radiation causes damage to DNA, specifically 
on the p53 gene, a gene with tumor suppressive functions. Once 
this gene is mutated, it can no longer act as an anti-oncogene, 
and cancerous skin cells can metastasize. 
Methods
The research discussed in this paper was obtained from various 
published articles from the Touro Library and Google Scholar. 
Most of the articles present original information from studies 
and experiments of tissue and DNA
Discussion: Ultraviolet Radiation
The electromagnetic spectrum is a range of all forms of light, 
based in their frequency and wavelength. Visible light has wave-
lengths between 400 and 750 nanometers. UV radiation has 
shorter wavelengths and therefore higher frequency than visible 
light. Wavelengths of UV rays are 100 to 400 nanometers (US 
EPA, 2018). UV radiation is divided into 3 categories, UVA, UVB, 
and UVC. UVA has wavelengths between 320 to 400 nanometers, 
and can penetrate through the ozone layer, a protective layer of 
gas that surrounds earth and protects from harmful UV rays. UVB 
ranges from 290 to 320 nanometers, and is mostly blocked by the 
ozone layer, but some rays do come through the ozone and reach 
Earth. UVC ranges from 100 to 290 nanometers, and is almost 
entirely blocked by the ozone (Chouinard et al., 2001). 
Although UVB is mostly blocked by the ozone, as the strato-
spheric ozone layer is depleted, UV radiation is more potent 
and can raise the instances of skin cancer (Nakazawa et al., 
1994). UVB has been proven to be the major factor to induce 
DNA damage, because that specific wavelength can be absorbed 
by the nucleotide bases that make up DNA (Ichihashi et al., 
2003). Wavelengths below 290 nanometers usually get absorbed 
on the surface of the epidermis, and thus do not cause BCC and 
SCC (Radosevich, 2014).
Only ten percent of sunlight is UV radiation, as the rest 
comes from visible and infrared light. Of the ten percent, ninety 
five percent of it is UVA radiation, and only five percent is UVB 
(Bowes, 2012). A little bit of UVB is essential for the produc-
tion of Vitamin D, however, excessive exposure to it can cause 
erythema, cataracts, or skin cancer (Radosevich, 2014). Even 
small amounts of UVB exposure can be dangerous if there are 
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repeated incidents, as it will affect the cell formation in the skin 
by attenuating the basement membrane structure (Chouinard 
et al., 2001). The weakened membrane allows the UV radiation 
to reach a person’s DNA, specifically that of the p53 gene, a 
gene with tumor suppressive functions. Once this gene is mu-
tated, it can no longer act as an anti-oncogene. 
Function of p53
The p53 protein is made from a 20 Kb gene on the short arm 
of chromosome 17, which codes for a phosphoprotein involved 
in transcription and regulation in the cell cycle (Benjamin 
and Ananthaswamy, 2007). It has been dubbed the name “the 
guardian of the genome” and “the cellular gatekeeper” (Zilfou 
and Lowe, 2009). P53 is known this way because of its tumor 
suppressive functions. P53 gets activated via phosphorylation 
at a serine residue, at either the amino or carboxyl terminus 
(Benjamin et al., 2007). Then, it can inhibit the growth of cancer-
ous causing cell cycle arrest, apoptosis, and DNA repair (Ouhtit 
et al., 1998). Cell cycle arrest gives the cell the opportunity to 
correct DNA complications before the DNA gets replicated. 
Since the cell is not continuing mitosis at that point, no new 
cells will be formed with the incorrect DNA. On the other 
hand, when p53 causes apoptosis, the cancerous cell gets killed 
and destroyed, and therefore cannot proliferate and become a 
cancerous growth(Benjamin et al., 2007). Moreover, it can pre-
serve the correct form of the DNA (Einspahr et al., 1999). This 
is accomplished by “negative growth regulation,” which essen-
tially means that p53 stops cell division and proliferation of cells 
with abnormal DNA (Benjamin and Ananthaswamy, 2007).
Mutation of p53 is usually a missense mutation, a mutation 
which switches nucleotide in the DNA sequence. Therefore, the 
codon in the DNA will code for a different amino acid. Such a 
change affects the protein’s function if the mutation results in 
an amino acid change in the binding site of the protein, which is 
the case in the p53 missense mutations (Einspahr et al., 1999). 
When p53 is mutated it loses its ability to act as an anti-on-
cogene and suppress tumors, so growth of tumors are then able 
to grow and form. Tumorigenesis gets inhibited when p53 binds 
DNA and triggers a different gene to make p21. Once p21 is 
made, it reacts with a cell division stimulating protein(cdk2), and 
forms a complex with it. As a result, cdk2 is inactivated and the 
cell cannot continue with cell division. By stopping cell division, 
the cells cannot multiply and grow to form a tumor. However, 
when p53 gets mutated, it can no longer interact with DNA 
the same way, so p21 is not produced, cdk2 is not inhibited 
and cancerous cells can continue multiplying and form a tumor 
(National Center for Biotechnology Information (US), 1998).
UV Damage Adducts: Cyclobutane Pyrimidine 
dimers and 6-4 Photoproducts
BCC and SCC are mainly caused by UV radiation(You et al., 2001). 
Studies have shown that 58% of SCC has a mutation on the p53 
gene(Benjamin et al., 2007).UVB specifically causes bulky linkages 
between pyrimidine dimers(Sarasin and Giglia-Mari, 2002). DNA 
is made up of nucleic acid, which is a linear polymer of nucleo-
tides. Each nucleotide contains a ribose sugar, phosphate group 
and a nitrogen base. There are four different nitrogen bases found 
in DNA: adenine, guanine, cytosine and thymine. Adenine and 
guanine have similar ring structures and are classified as purines. 
Cytosine (C) and thymine (T) have a similar ring structure (differ-
ent than that of the purines) and are classified as pyrimidines. A 
pyrimidine dimer can form when two pyrimidine nucleotides are 
adjacent to each other on a DNA strand.
These pyrimidine dimer linkages can mainly be corrected 
by nucleotide excision repair. (Sarasin and Giglia-Mari, 2002). 
Nucleotide excision repair can repair UV induced pyrimidine 
dimer linkages before DNA replication, or after replication by 
using a specific DNA polymerase which corrects DNA. The re-
pair process begins with recognizing the damage on the DNA 
.The DNA is then cut on either side of the lesion on a single 
strand of DNA, and the damaged area is extracted. Next, the 
removed segment is replaced with new nucleotides to recreate 
the DNA properly. The process is complete when ligation oc-
curs, and the newly formed DNA segment is linked to rest of 
the strand. Two approaches to nucleotide excision repair are 
transcription coupled repair, which is done on DNA strands that 
are actively transcribed, and global genome repair which occurs 
on the non-transcribed strand of DNA. Transcription coupled 
repair requires is generally faster than global genome repair in 
DNA repair (de Gruijl and Rebel, 2008). Global genome repair 
deals with damage recognition and correction of pyrimidine 
dimer linkages. The damage recognition stage takes some time, 
depending on the effect of the damage on the structure of the 
DNA helix, and is the rate limiting aspect in repair, which makes 
global genome repair slower than transcription coupled repair 
(Ichihashi et al., 2003).The significance of nucleotide excision 
repair can be understood by studying patients with Xeroderma 
Pigmentosum, a genetic disease in which DNA repair from UV 
radiation, nucleotide excision repair, is impaired. Individuals with 
this disorder have a much higher rate of developing skin cancer, 
since they have more uncorrected pyrimidine dimer linkages 
that lead to mutation (de Gruijl and Rebel, 2008). Early growth 
of skin cancer is noted in Xeroderma Pigmentosum patients 
with a frequency of approximately 4000 more than regular peo-
ple (Sarasin and Giglia-Mari, 2002).
UVB can cause two types of DNA lesions on the p53 protein, 
cyclobutane pyrimidine dimers (CPD) and pyrimidine 6-4 pyrim-
idone photoproducts (6-4PP). Both of these linkages lead to C 
to T or CC to TT mutations, known as “signature mutations,” on 
gene p53 in DNA (You et al., 2001). In a study of tissue with 
different levels of sun exposure and sun damage, it was noted that 
74% of the mutation of p53 occurred at dipyrimidine sites, and 
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54% were C to T, or CC to TT mutations (Einspahr et al., 1999).
CPDs are the cause of 80% of the DNA mutations, since 6-4 
PP can be repaired more efficiently (You et al., 2001). The repair 
of 6-4PP can occur within less than 24 hours of the UV exposure 
(de Gruijl and Rebel, 2008). In fact, 56% of keratinocytes correct-
ed the 6-4 PP within 24 hours. Conversely, only 11% of CPDs 
were remedied within the first 24 hours after UVB exposure 
(Chouinard et al., 2001). CPDs are less effectively repaired and 
can lead to mutation of p53 and then skin cancer. Moreover, there 
are generally CPDs are 3 to 4 times more commonly formed 
than 6-4 PP (de Gruijl and Rebel, 2008). Experimentally it has 
been observed that 6-4 PP were formed significantly less often 
than CPD overall, and even more rare in experiments with solar 
UV simulation. Therefore, in natural sunlight, 6-4 PP are found at a 
much lower percentage than CPDs (You et al., 2001).
UVB from sunlight will cause CPD formation, especially at 
pyrimidine dimers which have methylated cytosine nucleotides 
(You, 2000). A CCG sequence with a methylated cytosine is a 
common place for mutation, since a methylated cytosine is less 
stable than regular cytosine and can be deaminated easily. The 
deamination of a methyl cytosine yields a thymine nucleotide, a 
DNA mutation (Sarasin and Giglia-Mari, 2002). CPDs only can 
cause mutations to develop after the deamination of a methyl-
cytosine in adduct (You et al., 2001). The CCG sequence codes 
for the amino acid arginine, and when the cytosine nucleotide 
gets converted to thymine, the sequence now codes for tryp-
tophan. This switch of amino acids is extremely important to 
the p53 gene since that arginine is found at p53’s binding site 
(Sarasin and Giglia-Mari, 2002). Since arginine and tryptophan 
have different side chains they react differently and thus will 
affect the binding of p53 to the target DNA. Arginine contains 
a second amino group on its side chain, which can act as a base 
and get protonated. Tryptophan side chain is two fused aromatic 
rings, and the nitrogen in its side chain is an extremely weak 
base, as it loses its aromaticity when protonated. Therefore, mu-
tation and transition of the nucleotide at this sequence greatly 
affects the function and capabilities of p53. 
Mutation of p53 and Carcinogenesis
Genetic mutations of p53 have clear correlations with the 
growth of cancer. When p53 is inactivated or mutated, the skin 
becomes more vulnerable to carcinogenesis (de Gruijl and 
Rebel, 2008). UV radiation provokes the growth of skin tumors, 
mostly SCC and BCC(You et al., 2001). Basal cells are on the 
bottom layer of the epidermis and rise slowly as new layers 
grow beneath them. As a result, these cells stay in the epidermis 
the longest, until the rise from the bottom layer until they even-
tually reach the top and die, Therefore UV damage to these cells 
has a long term capability to cause cancer, since they are in the 
skin for the longest time (de Gruijl, 2002).
 P53 mutation is found in about 50% of all types of cancer. UV 
radiation causes specific mutations in p53 which can result in 
skin cancer. It causes cancerous growths by stimulating different 
growth factors and activating their receptors. Moreover, each 
instance of UV exposure helps mutated cells reproduce and 
take over healthy epidermal cells, even if it does not induce new 
mutations. Although the cell has protective mechanisms against 
DNA mutation, UV sometimes can still cause DNA damage. 
Buildup of mutations on critical genes leads to carcinogenesis 
of the skin. Many mutations of p53 are even noted in normal 
looking skin which has been exposed to the sun (Benjamin and 
Ananthaswamy, 2007). Most of the mutations found in p53 in 
people with skin cancer, prove to have UV radiation as the cause. 
Once p53 is mutated, it affects the availability for apoptosis to 
occur in keratinocytes, as a response to UV radiation. Apoptosis 
is a programmed cell death. In tissues that are constantly re-
newing, apoptosis is involved in homeostasis , as more cells are 
reproducing, others are destroyed through apoptosis. When a 
gene which deals with apoptosis is mutated, it can result in too 
much growth, since cells are not dying as new cells are being 
formed. Moreover, p53 maintains “genomic integrity” by repair-
ing the DNA or causing apoptosis in a cell with mutant DNA. 
However, when p53 is mutated, it can no longer function in this 
way. In cancer, generally the mutation of p53 occurs further into 
the tumorigenic process. In contrast, in NMSC the mutation 
in p53 is an early step in carcinogenesis (Einspahr et al., 1999).
Mutated cells have overexpression of the p53 protein and form 
“p53 patches.” Most p53 patches had signature UVB damage. The 
mutation spectrum observed is quite similar to the mutation 
spectrum of SCC. As a result of the damage, the functions of p53, 
like apoptosis and cell cycle arrest, are interrupted. Since these 
processes generally occur to prevent cancerous growth, UV in-
duced damage which impacts them likely occurs early in cancer 
development. Although all p53 have the potential to become SCC, 
only a few do actually become cancerous. Approximately 8000 to 
40000 p53 patches are around by the time the first tumorous 
growth begins (de Gruijl and Rebel, 2008). 
UV induced mutations in p53 most likely occur as an early 
step in the process of skin carcinogenesis. However in other 
cancers, like colon cancer p53 mutations generally occur 
later in the development of the cancer, particularly related to 
the change from an adenoma to a carcinoma (Benjamin and 
Ananthaswamy, 2007). This phase of cancer is much later in the 
development as cancer progresses from normal epithelium, to 
abnormal epithelium, to a small adenoma, to larger adenoma, 
and finally to a carcinoma.
Actinic keratosis (AK) is a precancerous lesion which can lead 
to SCC. The frequency of a p53 mutation has been studied with 
different conditions of skin. In a particular study, the frequency 
of a p53 mutation in SCC was 53.8%, in AK it was 62.5%, in sun 
damaged skin it was 38.5%, and in normal skin it was 14.3%. 
The mutation is observed to have a higher frequency in skin 
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from an AK lesion. This could be because the tissue samples 
obtained from AK lesions are closer to the surface of the skin, 
and the tissue samples of SCC are deeper in the skin and could 
be contaminated from the stromal tissue(Einspahr et al., 1999).
 Approximately 89% of the mutations found in AK, were UV 
signature mutations. Therefore, it is believed that AK is the 
growth of mutated, cancerous cells. Moreover, the UV does not 
only cause great increase in reproduction of the mutated cells, 
but also causes apoptosis of normal cells in the area of hyper-
proliferation (Benjamin and Ananthaswamy, 2007). Various stud-
ies of skin have found a lot of p53 mutations in BCC and SCC. 
Samples of 342 tissues from patients with aggressive and nonag-
gressive cases of SCC and BCC were studied for p53 changes. In 
BCC, 66% of the aggressive cases and 38% of the non-aggressive 
cases had p53 changes. In SCC, p53 mutations were observed 
in 35% of the aggressive cases and 50% of non-aggressive cases 
(Benjamin and Ananthaswamy, 2007). 
In a study of eight samples of NMSC, from the head and neck, 
7 of the samples (88%) had p53 mutation. Six of the tissues had 
at least two amino acid changes as a result of the mutation, which 
were mainly at the binding site of p53 (Kanjilal et al., 1995). 
In Approximately 38-50% of patients with NMSC, a second 
tumor grows within five years of the first one. A patient with 
skin cancer needs a lot of medical intervention, surgical proce-
dures, and sometimes radiotherapy (Kanjilal et al., 1995). 
Prevention
Since NMSC can be caused by UVB from sunlight, protection 
from the sun’s powerful rays would be a great means of pre-
vention. DNA damage and mutation of p53 are the beginning 
steps of the development of skin cancer, by preventing them 
skin cancer can be prevented as well (El-Deiry, 2007). Sunscreen 
can effectively protect the skin from UV induced DNA damage 
and p53 mutation, since it can absorb or reflect the harmful 
UV rays so they do not penetrate the cells (Radosevich, 2014). 
Sunscreens have been proven to protect against DNA damage, 
skin aging, sunburn, immunosuppression, and skin carcinogene-
sis. Although it can be obviously observed that sunscreen pre-
vents erythema and sunburn, experiments and studies must be 
conducted to see if it is useful in preventing deeper damage, like 
p53 mutation (Benjamin et al., 2007).
The effectiveness of sunscreen in preventing mutations, can 
be proven based on a murine experiment. After conducting 
experiments to prove that UV radiation causes p53 mutation, 
another experiment was conducted to understand if sunscreen 
can prevent the p53 mutations from happening. Both sunscreens 
used in this experiment had an SPF (sunburn protection factor) 
of 15. One sunscreen had only UVB protection, and the other 
had protection for UVB as well as protection from UVA. The 
mice who had the UVB sunscreen, developed p53 mutations 
88% less than mice without sun protection, and those with UVB 
+UVA sunscreen had 92% less mutations. Therefore, this exper-
iment clearly displayed the capability of sunscreen to inhibit p53 
mutation. Since p53 mutation is an integral step in carcinogene-
sis, if mutation is prevented, skin cancer is less likely to develop 
(Ananthaswamy, Ullrich and Kripke, 2002).
Another strategic tactic to avoid or delay carcinogenesis is 
to minimize sun exposure. Some UV exposure is necessary for 
the body, as it plays an important role in the synthesis of vitamin 
D , excess exposure can cause skin cancer (Radosevich, 2014). 
Studies have proven that p53 patches grow more when exposed 
to additional UV exposure. Although reducing UV exposure 
cannot eliminate the possibility of skin cancer, it can delay its 
progression and development(Benjamin et al., 2007).
The Environmental Protection Agency (EPA) notes that at noon 
the sun’s rays are most powerful as they travel the least distance 
to reach Earth. Therefore, it would be wise to avoid unnecessary 
UV exposure at that time. The EPA also recommends applying 
sunscreen, seeking shade when possible, keeping aware the UV 
index, and being exceptionally cautious around areas that can re-
flect the sun’s rays, such as water, snow, and sand (US EPA, 2018). 
Conclusion
UVB induced mutation of p53 leads to the development of skin 
cancer. UV radiation causes the formation of pyrimidine dimers 
on the p53 protein. P53 is an anti-oncogene, which prevents tu-
morigenesis by causing cell cycle arrest or apoptosis. When p53 
is damaged by UV mutation it can longer function and cancerous 
basal and squamous cells can proliferate and grow. Cancerous 
areas show overexpression of p53 and are referred to as “p53 
patches.” These patches will grow more when exposed to more 
UV radiation, even if the radiation will not cause a new mutation 
to form in that instance. Sunscreen usage and minimization of 
sun exposure are affective approaches to prevent UV damage of 
p53 and skin carcinogenesis.
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